Generic drugs

brand vs generic drugsWhat is a generic drug?

Generic drug– or a reproduced drug – is called a drug, the term of validity of the patent protection for which has already ended. Accordingly, the generic is not the exclusive property of the pharmaceutical company that developed it or owned the first license for its sale.

“Generic” – generic drug, produced by a similar technology, from the same raw material as the original. Typically, generics begin to be produced after the expiration of the patent for the original, but in some countries, including India, they are issued before the end of the patent. The original preparation can have up to 200-300 generics.

Generic drug act like original one?

Yes, generics have the same healing properties, because they contain the same basic components as in the original. Pharmacists recognized the safety of generics. After all, for fears, there are no objective grounds: the generic contains the same active drug substance as the original (patented) drug. Generic may differ from the original preparation by auxiliary substances (inactive ingredients, excipients, preservatives, dyes, etc.). But the accompanying impurities do not influence the process of treatment. Differences can also be observed in the most technological process of producing generics (for example, in the mechanism of tablet pressing). At the same time, generics do not differ from the original means for efficiency and safety, and are manufactured in strict accordance with established regulations and quality standards.

Who produces generics?

Do not think that all generics are produced by unknown, “strange” companies. Today, generics are produced by world-famous pharmaceutical companies that value their reputation. Moreover, half of the manufacturers of original drugs are engaged in the production of generics. To obtain permission to apply a generic drug on the territory of a particular country, the manufacturer must provide data on the conformity of the quality of the generic (bioequivalence) with respect to the proprietary analogue. This means that generics should contain the same ingredients and be as effective as the original drugs. People buy generics much more often than original drugs, even in such prosperous countries as the US or Sweden. And we are talking about those drugs that the world medical science and practice have identified as the most effective and necessary. Many generics have entered into the standards of treatment of a number of serious socially significant diseases, such as diseases of the central nervous system, oncological diseases.

Why do we get these drugs cheaper?

The merits of generics include low cost due to competition and (as a rule) a large experience of using the drug in practice. Generics are significantly cheaper (the difference is palpable – several times) than innovative drugs, since their manufacturers do not bear capital costs for developing, researching and advertising new drugs. Thus, firms that produce generics do not incur overheads associated with new developments and clinical trials. Their task is to create technologies for the production of a drug that has come out of patent protection, i.e. Repeat what was developed before them. Hence the more affordable price for the drug. In addition, strong competition from other generic companies also contributes to the establishment of low prices.